INS and Hypoglycemia: Another major unresolved issue is the premature insulin release under hypo-/normoglycemic conditions, as many PBA-based microgels begin to swell at low glucose concentrations [32,33,34,35,36,37,38], increasing the risk of hypoglycemia.